#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3536564	ADME	Drug level in dog liver microsomes treated with 10 uM ER-879819 after 60 mins in presence of NADH by LC-MS/MS method	Canis lupus familiaris	1	ALA3525952	assay format	Scientific Literature
2.	ALA3536565	ADME	Drug level in human liver microsomes treated with 10 uM ER-879819 after 60 mins in presence of NADH by LC-MS/MS method	Homo sapiens	1	ALA3525952	assay format	Scientific Literature
3.	ALA3531399	ADME	Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADPH after 60 mins by LC-MS/MS method	Homo sapiens	1	ALA3525952	single protein format	Scientific Literature
4.	ALA3531400	ADME	Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADH after 60 mins by LC-MS/MS method	Homo sapiens	1	ALA3525952	single protein format	Scientific Literature
5.	ALA3531504	ADME	Drug level in dog hepatocytes treated with 50 uM E7016 after 120 mins in presence of NADPH by LC-MS/MS method	Canis lupus familiaris	1	ALA3525952	cell-based format	Scientific Literature
6.	ALA3531505	ADME	Drug level in rat hepatocytes treated with 50 uM E7016 after 120 mins in presence of NADPH by LC-MS/MS method	Rattus norvegicus	1	ALA3525952	cell-based format	Scientific Literature
7.	ALA3531506	ADME	Drug level in human hepatocytes treated with 50 uM E7016 after 120 mins in presence of NADPH by LC-MS/MS method	Homo sapiens	1	ALA3525952	cell-based format	Scientific Literature
8.	ALA3531509	ADME	Drug level in dog liver S9 fraction treated with 50 uM E7016 after 60 mins in presence of NAD+ by LC-MS/MS method	Canis lupus familiaris	1	ALA3525952	subcellular format	Scientific Literature
9.	ALA3531510	ADME	Drug level in dog liver S9 fraction treated with 50 uM E7016 after 60 mins in presence of NADP+ by LC-MS/MS method	Canis lupus familiaris	1	ALA3525952	subcellular format	Scientific Literature
10.	ALA3531511	ADME	Drug level in human liver S9 fraction treated with 50 uM E7016 after 60 mins in presence of NAD+ by LC-MS/MS method	Homo sapiens	1	ALA3525952	subcellular format	Scientific Literature
11.	ALA3531512	ADME	Drug level in human liver S9 fraction treated with 50 uM E7016 after 60 mins in presence of NADP+ by LC-MS/MS method	Homo sapiens	1	ALA3525952	subcellular format	Scientific Literature
12.	ALA3531513	ADME	Drug level in dog liver S9 fraction treated with 50 uM E7016 after 60 mins in presence of NADP+ by LC-MS/MS method relative to in presence of NAD+	Canis lupus familiaris	1	ALA3525952	subcellular format	Scientific Literature
13.	ALA3531514	ADME	Drug level in human liver S9 fraction treated with 50 uM E7016 after 60 mins in presence of NADP+ by LC-MS/MS method relative to in presence of NAD+	Homo sapiens	1	ALA3525952	subcellular format	Scientific Literature
14.	ALA3531519	ADME	Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of rat liver cytosolic fractions after 60 mins by LC-MS/MS method	Homo sapiens	1	ALA3525952	tissue-based format	Scientific Literature
15.	ALA3531520	ADME	Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of human liver cytosolic fractions after 60 mins by LC-MS/MS method	Homo sapiens	1	ALA3525952	tissue-based format	Scientific Literature
16.	ALA3531521	ADME	Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of dog liver cytosolic fractions after 60 mins by LC-MS/MS method	Homo sapiens	1	ALA3525952	tissue-based format	Scientific Literature